Tower Research Capital (TRC)’s Pasithea Therapeutics KTTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $910 | Sell |
1,261
-2,006
| -61% | -$1.45K | ﹤0.01% | 4914 |
|
|
2025
Q1 | $4.25K | Buy |
3,267
+1,381
| +73% | +$1.8K | ﹤0.01% | 4282 |
|
|
2024
Q4 | $5.94K | Buy |
1,886
+1,285
| +214% | +$4.05K | ﹤0.01% | 4222 |
|
|
2024
Q3 | $3.26K | Sell |
601
-1,206
| -67% | -$6.54K | ﹤0.01% | 4875 |
|
|
2024
Q2 | $9.15K | Buy |
1,807
+462
| +34% | +$2.34K | ﹤0.01% | 4284 |
|
|
2024
Q1 | $9.75K | Buy |
1,345
+725
| +117% | +$5.26K | ﹤0.01% | 3797 |
|
|
2023
Q4 | $4.59K | Sell |
620
-5
| -0.8% | -$37 | ﹤0.01% | 4939 |
|
|
2023
Q3 | $6K | Buy |
625
+1
| +0.2% | +$10 | ﹤0.01% | 4656 |
|
|
2023
Q2 | $6.12K | Sell |
624
-6
| -1% | -$59 | ﹤0.01% | 4712 |
|
|
2023
Q1 | $5K | Sell |
630
-122
| -16% | -$968 | ﹤0.01% | 4973 |
|
|
2022
Q4 | $10K | Buy |
752
+469
| +166% | +$6.24K | ﹤0.01% | 4022 |
|
|
2022
Q3 | $7K | Buy |
283
+170
| +150% | +$4.21K | ﹤0.01% | 4896 |
|
|
2022
Q2 | $2K | Buy |
+113
| New | +$2K | ﹤0.01% | 5559 |
|
|
2022
Q1 | – | Sell |
-1,469
| Closed | -$52K | – | 6347 |
|
|
2021
Q4 | $52K | Buy |
1,469
+1,377
| +1,497% | +$48.7K | ﹤0.01% | 2732 |
|
|
2021
Q3 | $6K | Buy |
+92
| New | +$6K | ﹤0.01% | 4760 |
|